<p>Basel Medical Group Ltd. has disclosed a delay in its financial reporting after receiving a Nasdaq notification for not including an auditor’s opinion in its annual report on Form 20-F for the fiscal year ended June 30, 2025. The company now has 60 days to submit a compliance plan, with the possibility of an extension of up to 180 days. Trading of its shares on Nasdaq remains unaffected. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-025588), on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

BMGL

<p>Basel Medical Group Ltd. missed the deadline for its annual financial report, receiving a Nasdaq notification for not including an auditor’s opinion in its Form 20-F for the fiscal year ended June 30, 2025. The company has 60 days to submit a compliance plan, with a possible extension of up to 180 days. Trading on Nasdaq remains unaffected.</p>

Basel Medical Group Misses Deadline for Annual Financial Report